Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
reports
Elite Pharmaceuticals (ELTP) Stock Price & Analysis
77 Followers
ELTP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.03 - $0.05
Previous Close$0.03
Volume420.06K
Average Volume (3M)332.77K
Market Cap
$30.42M
Enterprise Value$28.49M
Total Cash (Recent Filing)$17.91M
Total Debt (Recent Filing)$15.98M
Price to Earnings (P/E)4.2
Beta0.60
Next Earnings
Jun 14, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding1,013,915,081
10 Day Avg. Volume281,700
30 Day Avg. Volume332,774
Standard Deviation0.14
R-Squared0.00795
Alpha-0.00933
Financial Highlights & Ratios
Price to Book (P/B)1.31
Price to Sales (P/S)0.93
Price to Cash Flow (P/CF)15.60
P/FCF Ratio-8.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.86
Enterprise Value/Gross Profit1.93
Enterprise Value/Ebitda3.69
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Elite Pharmaceuticals News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ELTP FAQ
What was Elite Pharmaceuticals’s price range in the past 12 months?
Elite Pharmaceuticals lowest stock price was $0.03 and its highest was $0.05 in the past 12 months.
What is Elite Pharmaceuticals’s market cap?
Currently, no data Available
When is Elite Pharmaceuticals’s upcoming earnings report date?
Elite Pharmaceuticals’s upcoming earnings report date is Jun 14, 2023 which is in 76 days.
How were Elite Pharmaceuticals’s earnings last quarter?
Elite Pharmaceuticals released its earnings results on Feb 14, 2023. The company reported $0.003 earnings per share for the quarter, beating the consensus estimate of N/A by $0.003.
Is Elite Pharmaceuticals overvalued?
According to Wall Street analysts Elite Pharmaceuticals’s price is currently Overvalued.
Does Elite Pharmaceuticals pay dividends?
Elite Pharmaceuticals does not currently pay dividends.
What is Elite Pharmaceuticals’s EPS estimate?
Elite Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Elite Pharmaceuticals have?
Elite Pharmaceuticals has 1,013,915,100 shares outstanding.
What happened to Elite Pharmaceuticals’s price movement after its last earnings report?
Elite Pharmaceuticals reported an EPS of $0.003 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Elite Pharmaceuticals?
Among the largest hedge funds holding Elite Pharmaceuticals’s share is Fisher Asset Management LLC. It holds Elite Pharmaceuticals’s shares valued at N/A.
---
Elite Pharmaceuticals Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-14.28%
12-Months-Change
Fundamentals
Return on Equity
27.26%
Trailing 12-Months
Asset Growth
65.01%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Elite Pharmaceuticals
Elite Pharmaceuticals, Inc. engages in the development and manufacture of pharmacological abuse-deterrent opioid products. It operates through the Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) segments. The ANDA segment includes generic pharmaceuticals. The NDA segment comprises the branded pharmaceuticals. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ.
---
---